The Latest Cardiac and Vascular News
BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced that it had been awarded a €2.5 million grant by the European Commission […]
SUNNYVALE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, announced today the commencement of a proposed underwritten public offering of $100 million of shares of its common stock. In addition, Silk Road Medical expects […]
MIAMI LAKES, Fla., Oct. 18, 2022 /PRNewswire/ — Cordis, a worldwide leader in the development and manufacturing of interventional cardiovascular and endovascular technologies, today announced its acquisition, subject to customary closing conditions including regulatory approvals, of MedAlliance, a Switzerland-based company at the forefront of transformative drug-eluting balloons. By acquiring MedAlliance, Cordis has the potential to […]
MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced it has appointed Alexey (Alex) Nepogodiev as Executive Vice President, Global Marketing. Alex possesses more than 20 years of leadership experience in successfully developing new markets and therapies in interventional cardiology, structural heart, and endovascular businesses worldwide. […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its at-the-market (ATM) facility, raising gross proceeds of $7.6 million. The Company sold 1,072,246 shares of common stock at a weighted average price of $7.09 per share, as adjusted for a reverse […]
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday. In his more than 30 years in the medical technology arena, Mr. Casciaro has developed a track record of success leading and growing both private and […]
Issuance of convertible bonds into shares for an amount of €3.9 M to historical shareholders Issuance of simple bonds with attached warrants to a new French investor for €2.0 M PARIS–(BUSINESS WIRE)–Regulatory News: Acticor Biotech (Euronext Growth Paris – ISIN : FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing an […]
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Confluent Medical Technologies, Inc. (“Confluent”) today announced that Matthew K. Eckl has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022. “We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent’s Chief Executive Officer. “Matt has exceptional experience in finance and […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it has entered into a new, five-year credit agreement with MidCap Financial (“MidCap”), comprised of up to $100 million in term loans and a $25 […]
Dr. Johnston will serve as chief of cardiac surgery and surgical director of Bluhm Cardiovascular Institute CHICAGO, Oct. 13, 2022 /PRNewswire/ — Nationally recognized cardiothoracic surgeon, Douglas R. Johnston, MD, has been named surgical director of Northwestern Medicine’s Bluhm Cardiovascular Institute and chief of the division of cardiac surgery at Northwestern Memorial Hospital and Northwestern University Feinberg School […]
